This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Addario Lung Cancer Medical Institute (ALCMI)
alcmi.bsky.social
did:plc:bxzk4m7k4l4pqhhbb3guu3qx
Dr. Adrien Rousseau, and colleagues at ALCMI consortium member Gustave Roussy have found that some medications taken at the beginning of immunotherapy can negatively impact survival in NSCLC patients. #lungcancer
https://www.managedhealthcareexecutive.com/view/common-medications-linked-to-worse-survival-in-lung-cancer-patients-receiving-keytruda
2025-09-28T14:01:51.755Z